Beta
329679

A prospective randomized controlled study comparing intravenous dexmedetomidine plus ketamine combination with intravenous dexmedetomidine alone for awake fibreoptic nasotracheal

Article

Last updated: 29 Dec 2024

Subjects

-

Tags

-

Abstract

Background
The purpose of this study was to compare the efficacy and safety of dexmedetomidine versus dexmedetomidine and ketamine for sedation during awake fibreoptic intubation (FOI) in patients posted for elective surgeries. Ninety-eight American Society of Anesthesiologists Physical Status (ASA-PS) I–II patients with difficult airway and scheduled for elective surgeries were enrolled in this study after institutional ethics committee approval. Patients were randomly allocated into 2 groups, i.e. 49 patients in each group. Group D patients received 1 μg/kg dexmedetomidine IV over 10 min in 100-mL normal saline followed by a continuous infusion at 0.5 μg/kg/h till FOI and 5-mL normal saline followed by saline infusion. Group DK patients received 1 μg/kg dexmedetomidine IV over 10 min in 100-mL normal saline. Further, they received IV ketamine 15 mg as a bolus of 5 mL, followed by continuous infusion of ketamine at 20 mg/h until the end of intubation. The primary objective was to compare the efficacy of the combination of IV dexmedetomidine and ketamine with IV dexmedetomidine alone as sedation for FOI. Vocal cord movement, sedation, coughing, facial grimace score, recall of procedure, and haemodynamics were also compared in both groups.
Results
Demographic data, vocal cord movement, cough score, facial grimace score, total drugs used, hoarseness, sore throat and level of recall were comparable in both groups. Haemodynamics were significantly better in group DK at 2, 3, 4 and 5 min compared to group D.
Conclusions
Addition of ketamine to dexmedetomidine did not improve intubating conditions, reduce cough or improve recall of FOI. However, patients remain sedated when ketamine was used with dexmedetomidine. The study was not registered prospectively in any clinical trial registry.

DOI

10.1186/s42077-021-00133-x

Keywords

Fibreoptic, Intubation, Dexmedetomidine, Ketamine, Sedation

Authors

First Name

Deepali

Last Name

Jamgade

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Gajanan

Last Name

Fultambkar

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Sudheer

Last Name

Dara

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

B.

Last Name

Vijayanand

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Abhijit

Last Name

Nair

MiddleName

-

Affiliation

-

Email

abhijitnair@rediffmail.com

City

-

Orcid

0000-0003-2506-0301

Volume

13

Article Issue

1

Related Issue

44739

Issue Date

2021-01-01

Receive Date

2021-02-09

Publish Date

2021-02-27

Print ISSN

1687-7934

Online ISSN

2090-925X

Link

https://asja.journals.ekb.eg/article_329679.html

Detail API

https://asja.journals.ekb.eg/service?article_code=329679

Order

329,679

Publication Type

Journal

Publication Title

Ain-Shams Journal of Anesthesiology

Publication Link

https://asja.journals.ekb.eg/

MainTitle

A prospective randomized controlled study comparing intravenous dexmedetomidine plus ketamine combination with intravenous dexmedetomidine alone for awake fibreoptic nasotracheal intubation

Details

Type

Article

Created At

20 Dec 2024